Issue 4, 2021

Engineered drug-loaded cells and cell derivatives as a delivery platform for cancer immunotherapy

Abstract

Cancer immunotherapy, which provides durable clinical responses by restoring or boosting the patient's immune system to fight cancer, has become a promising strategy for cancer treatment. However, modest response rates and on-target off-tumor toxicity largely limit extensive implementation of this approach in clinical settings. Advances in drug delivery and combination with other cancer treatments are able to effectively promote the potency of cancer immunotherapy. Engineered natural particulates, such as cells and their derivatives, have been recently developed as prospective drug delivery systems that comprehensively combine genetic engineering, synthetic materials, and nanotechnology to enhance anticancer efficacy. Here, recent advances in improving cancer immunotherapy have been summarized with a focus on using functionalized intact cells and cell derivatives including cell membranes and extracellular vesicles as drug vehicles. The advantages and challenges of these unique systems have been further elucidated in terms of clinical translation. The results presented in this review would contribute to the development of advanced therapies for treating cancers.

Graphical abstract: Engineered drug-loaded cells and cell derivatives as a delivery platform for cancer immunotherapy

Article information

Article type
Review Article
Submitted
01 okt 2020
Accepted
02 noy 2020
First published
02 noy 2020

Biomater. Sci., 2021,9, 1104-1116

Engineered drug-loaded cells and cell derivatives as a delivery platform for cancer immunotherapy

L. Wang and J. Liu, Biomater. Sci., 2021, 9, 1104 DOI: 10.1039/D0BM01676D

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements